文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

全身磁共振成像中无症状多发性骨髓瘤患者局灶性病变的预后意义。

Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma.

机构信息

Department of Hematology and Oncology, University Hospital Heidelberg, Heidelberg, Germany.

出版信息

J Clin Oncol. 2010 Mar 20;28(9):1606-10. doi: 10.1200/JCO.2009.25.5356. Epub 2010 Feb 22.


DOI:10.1200/JCO.2009.25.5356
PMID:20177023
Abstract

PURPOSE: With whole-body magnetic resonance imaging (wb-MRI), almost the whole bone marrow compartment can be examined in patients with monoclonal plasma cell disease. Focal lesions (FLs) detected by spinal MRI have been of prognostic significance in symptomatic multiple myeloma (sMM). In this study, we investigated the prognostic significance of FLs in wb-MRI in patients with asymptomatic multiple myeloma (aMM). PATIENTS AND METHODS: Wb-MRI was performed in 149 patients with aMM. The prognostic significance of the presence and absence, as well as the number, of FLs for progression into sMM was analyzed. RESULTS: FLs were present in 28% of patients. The presence per se of FLs and a number of greater than one FL were the strongest adverse prognostic factors for progression into sMM (P < .001) in multivariate analysis. A diffuse infiltration pattern in MRI, a monoclonal protein of 40 g/L or greater, and a plasma cell infiltration in bone marrow of 20% or greater were other adverse prognostic factors for progression-free survival in univariate analysis. CONCLUSION: We recommend use of wb-MRI for risk stratification of patients with asymptomatic multiple myeloma.

摘要

目的:全身磁共振成像(wb-MRI)可检查单克隆浆细胞疾病患者几乎整个骨髓腔。脊髓 MRI 检测到的局灶性病变(FL)对有症状多发性骨髓瘤(sMM)的预后有意义。本研究旨在探讨无症状多发性骨髓瘤(aMM)患者 wb-MRI 中 FL 的预后意义。

患者和方法:对 149 例 aMM 患者进行 wb-MRI 检查。分析 FL 的存在、数量以及有无 FL 对进展为 sMM 的影响。

结果:28%的患者存在 FL。多变量分析显示,FL 的存在及其数量>1 是进展为 sMM 的最强预后不良因素(P<.001)。MRI 弥漫性浸润模式、单克隆蛋白>40 g/L 和骨髓浆细胞浸润>20%也是无进展生存期的其他不良预后因素。

结论:我们建议对无症状多发性骨髓瘤患者进行 wb-MRI 风险分层。

相似文献

[1]
Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma.

J Clin Oncol. 2010-2-22

[2]
Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculation.

Clin Cancer Res. 2009-5-1

[3]
Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma.

Clin Cancer Res. 2007-1-15

[4]
Role of MRI for the diagnosis and prognosis of multiple myeloma.

Eur J Radiol. 2005-7

[5]
Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.

Int J Cancer. 2014-11-15

[6]
Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.

Eur J Radiol. 2013-5-28

[7]
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.

J Nucl Med. 2008-2

[8]
[Contribution of whole-body magnetic resonance in the diagnostics of monoclonal gammopathy of undetermined significance, multiple myeloma, and the assessment of Durie-Salmon Plus staging system].

Vnitr Lek. 2011-1

[9]
A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma.

Haematologica. 2015-6

[10]
Magnetic resonance imaging of the spine in plasma cell dyscrasias. A review.

Rev Rhum Engl Ed. 1996-12

引用本文的文献

[1]
Simultaneous whole-body multi-parametric 2-[F]FDG-PET/MRI in smoldering multiple myeloma assessment: diagnostic and prognostic impact.

Leukemia. 2025-8-7

[2]
ADC measurement in whole-body MRI for multiple myeloma: a three b-values vs. two b-values DWI comparison.

Radiol Med. 2025-6-3

[3]
[Expert consensus on the comprehensive management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma in China (2025)].

Zhonghua Xue Ye Xue Za Zhi. 2025-3-14

[4]
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma.

J Bone Oncol. 2025-2-28

[5]
Illuminating the Shadows: Innovation in Advanced Imaging Techniques for Myeloma Precursor Conditions.

Diagnostics (Basel). 2025-1-18

[6]
Autologous stem cell transplantation for multiple myeloma patients whose myeloma-defining event was SLiM.

Br J Haematol. 2025-2

[7]
Smoldering multiple myeloma: Integrating biology and risk into management.

Semin Hematol. 2025-2

[8]
Monoclonal Antibodies in Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Current Status and Future Directions.

Pharmaceuticals (Basel). 2024-7-6

[9]
Radiomic nomogram for predicting high-risk cytogenetic status in multiple myeloma based on fat-suppressed T2-weighted magnetic resonance imaging.

J Bone Oncol. 2024-6-15

[10]
Role of Non-Coding RNAs in Diagnosis, Prediction and Prognosis of Multiple Myeloma.

Cancers (Basel). 2024-3-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索